Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.

Diener, Hans-Christoph;Sacco, Ralph L;Yusuf, Salim;Cotton, Daniel;Laloux, Patrice;et.al.
(2008) The Lancet Neurology — Vol. 7, n° 10, p. 875-884 (2008)

Files

DienerHC-LancetNeurol-2008.pdf
  • Restricted Access
  • Adobe PDF
  • 175.24 KB
Request a copy

Details

Authors
  • Diener, Hans-Christoph
    Author
  • Sacco, Ralph L
    Author
  • Yusuf, Salim
    Author
  • Cotton, Daniel
    Author
  • Laloux, PatriceUCLouvain
    Collaborator
Show more
Abstract
Disability due to recurrent stroke and cognitive decline in patients with ischaemic stroke were not different between the two antiplatelet regimens and were not affected by the preventive use of telmisartan.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Diener, H.-C., Sacco, R. L., Yusuf, S., Cotton, D., Ounpuu, S., Lawton, W. A., Palesch, Y., Martin, R. H., Albers, G. W., Bath, P., Bornstein, N., Chan, B. P. L., Chen, S.-T., Cunha, L., Dahlöf, B., De Keyser, J., Donnan, G. A., Estol, C., Gorelick, P., et al. (2008). Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. The Lancet Neurology, 7(10), 875-884. https://doi.org/10.1016/S1474-4422(08)70198-4 (Original work published 2008)